BridgeMD
New treatment option for Schizophrenia
Official title Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients
ClinicalTrials.gov ID: NCT05329363
What this study is testing
- What it's testing
- Schizophrenia affects about 0.7% of the population. Poor insight, which is common in this disease, linked to poor drug compliance is leads to rehospitalisation with major impact on quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age between 18 and 65 years
- Patient with a diagnosed and reported schizophrenic disorder announced :
- Schizophrenia
- Schizoaffective disorder
- Or a diagnosed and reported Delusional Disorder
You likely can't join if
- Pregnant or breastfeeding woman
- Patient who does not speak French
- Participation in a psycho-education group in the last 2 years
- Patient under legal protection or guardianship
See the full eligibility criteria
- Age between 18 and 65 years
- Patient with a diagnosed and reported schizophrenic disorder announced :
- Schizophrenia
- Schizoaffective disorder
- Or a diagnosed and reported Delusional Disorder
- Express written consent by the participant after receiving information about the study
- Be able to communicate verbally
- Participant affiliated to a social security scheme
- Pregnant or breastfeeding woman
- Patient who does not speak French
- Participation in a psycho-education group in the last 2 years
- Patient under legal protection or guardianship
The study team makes the final eligibility decision.
Where it's taking place
- Blois, France
- Chinon, France
- Dreux, France
- Fleury-les-Aubrais, France
- La Roche-sur-Yon, France
- Neuilly-sur-Marne, France
- Rennes, France
- Saint-Maurice, France
- Sainte-Gemmes-sur-Loire, France
- Sotteville-lès-Rouen, France
- Tours, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Blois, France; Chinon, France; Dreux, France; Fleury-les-Aubrais, France; La Roche-sur-Yon, France; Neuilly-sur-Marne, France and 5 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.